Ameriprise’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
+45,292
| New | +$341K | ﹤0.01% | 3625 |
|
|
2025
Q1 | – | Sell |
-504,264
| Closed | -$6.14M | – | 3999 |
|
|
2024
Q4 | $6.14M | Buy |
504,264
+86,756
| +21% | +$1.06M | ﹤0.01% | 2205 |
|
|
2024
Q3 | $6.99M | Buy |
417,508
+13,630
| +3% | +$228K | ﹤0.01% | 2127 |
|
|
2024
Q2 | $7.04M | Sell |
403,878
-16,339
| -4% | -$285K | ﹤0.01% | 2026 |
|
|
2024
Q1 | $7.16M | Buy |
420,217
+365,296
| +665% | +$6.22M | ﹤0.01% | 2083 |
|
|
2023
Q4 | $560K | Sell |
54,921
-7,687
| -12% | -$78.3K | ﹤0.01% | 3417 |
|
|
2023
Q3 | $567K | Sell |
62,608
-258
| -0.4% | -$2.34K | ﹤0.01% | 3357 |
|
|
2023
Q2 | $676K | Buy |
62,866
+3,034
| +5% | +$32.6K | ﹤0.01% | 3326 |
|
|
2023
Q1 | $612K | Hold |
59,832
| – | – | ﹤0.01% | 3347 |
|
|
2022
Q4 | $631K | Buy |
+59,832
| New | +$631K | ﹤0.01% | 3315 |
|